{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T15:53:24Z","timestamp":1790610804617,"version":"4.1.0"},"reference-count":144,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,4,15]],"date-time":"2025-04-15T00:00:00Z","timestamp":1744675200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:p>Synovitis, acne, pustulosis, hyperostosis and osteitis (SAPHO) syndrome is a rare autoinflammatory disease characterized by cutaneous manifestations and osteoarticular damage. The pathogenesis of SAPHO syndrome has not yet been elucidated, but studies have shown that the abnormal bone metabolism of patients with SAPHO syndrome is most likely due to localized infections that induce immune disorders in the body. Although no standardized treatment protocols exist, based on existing case studies and data from open studies, we propose that the treatment of SAPHO syndrome can be categorized into three areas according to the symptomatic manifestations of the disease: (1) control of focal infections using antibiotics and tonsillectomy; (2) administration of DMARDs to manage disease progression; and (3) bone remodeling therapy with bisphosphonates to address abnormal bone metabolism. Furthermore, a comprehensive treatment approach tailored to the clinical manifestations of the patient can effectively alleviate symptoms and enhance quality of life.<\/jats:p>","DOI":"10.3389\/fimmu.2025.1560398","type":"journal-article","created":{"date-parts":[[2025,4,15]],"date-time":"2025-04-15T01:21:09Z","timestamp":1744680069000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":14,"title":["Therapeutic approaches for SAPHO syndrome from the perspective of pathogenesis: a review of the literature"],"prefix":"10.3389","volume":"16","author":[{"given":"Yunuo","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengjiao","family":"Gu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zixiang","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haixu","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luyao","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanjing","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuanhao","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chen","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2025,4,15]]},"reference":[{"key":"B1","article-title":"Acne-pustulosis-hyperostosis-osteitis syndrome. Results of a national survey. 85 cases","volume":"54","author":"Chamot","year":"1987","journal-title":"Rev Rhum Mal Osteoartic"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.3389\/fgene.2021.684520","article-title":"Integrative analysis of lncRNA-mRNA profile reveals potential predictors for SAPHO syndrome","volume":"12","author":"Sun","year":"2021","journal-title":"Front Genet"},{"key":"B3","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1007\/s11832-014-0627-7","article-title":"SAPHO syndrome: a review","volume":"9","author":"Rukavina","year":"2015","journal-title":"J Child Orthop"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1007\/s00296-023-05491-3","article-title":"SAPHO syndrome: current clinical, diagnostic and treatment approaches","volume":"44","author":"Demirci","year":"2024","journal-title":"Rheumatol Int"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1007\/s10067-020-05393-w","article-title":"Clinical characteristics of pediatric synovitis, acne, pustulosis, hyperostosis, and osteitis (SAPHO) syndrome: the first Chinese case series from a single center","volume":"40","author":"Wu","year":"2021","journal-title":"Clin Rheumatol"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1097\/md.0000000000021102","article-title":"Rapid induction of clinical remission in SAPHO syndrome using high-dose Tripterygium glycosides: A case report","volume":"99","author":"Gong","year":"2020","journal-title":"Med (Baltimore)"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2021.679111","article-title":"Case report: SAPHO syndrome mimicking bone metastases during treatment with pembrolizumab for non-small cell lung cancer","volume":"8","author":"Kubo","year":"2021","journal-title":"Front Med (Lausanne)"},{"key":"B8","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1016\/j.jbspin.2013.04.016","article-title":"SAPHO syndrome","volume":"81","author":"Canella","year":"2014","journal-title":"Joint Bone Spine"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1097\/rlu.0000000000003901","article-title":"68Ga-DOTA-FAPI-04 PET\/CT imaging in a case of SAPHO syndrome","volume":"47","author":"Xu","year":"2022","journal-title":"Clin Nucl Med"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2008.07.030","article-title":"SAPHO syndrome and infections","volume":"8","author":"Govoni","year":"2009","journal-title":"Autoimmun Rev"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1007\/s10067-006-0274-6","article-title":"Is SAPHO syndrome a target for antibiotic therapy","volume":"26","author":"Rozin","year":"2007","journal-title":"Clin Rheumatol"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1002\/1529-0131(199810)41:10<1889::aid-art23>3.3.co;2-6","article-title":"Propionibacterium acnes isolated from synovial tissue and fluid in a patient with oligoarthritis associated with acne and pustulosis","volume":"41","author":"Schaeverbeke","year":"1998","journal-title":"Arthritis Rheum"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1007\/s00330-003-1849-0","article-title":"Diagnostic management of patients with SAPHO syndrome: use of MR imaging to guide bone biopsy at CT for microbiological and histological work-up","volume":"13","author":"Kirchhoff","year":"2003","journal-title":"Eur Radiol"},{"key":"B14","article-title":"Propionibacterium acnes and SAPHO syndrome: a case report and literature review","volume":"25","author":"Colina","year":"2007","journal-title":"Clin Exp Rheumatol"},{"key":"B15","article-title":"Chronic sclerosing osteomyelitis (Garr\u00e9)","volume":"1982","author":"Collert","year":"1982","journal-title":"Clin Orthop Relat Res"},{"key":"B16","article-title":"Propionibacterium acnes isolated from sternal osteitis in a patient with SAPHO syndrome","volume":"23","author":"Kotilainen","year":"1996","journal-title":"J Rheumatol"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1136\/ard.49.5.337-b","article-title":"Propionibacterium acnes in a spondylitis with palmoplantar pustulosis","volume":"49","author":"Gerster","year":"1990","journal-title":"Ann Rheum Dis"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1097\/00000478-199611000-00008","article-title":"Osseous manifestations of SAPHO (synovitis, acne, pustulosis, hyperostosis, osteitis) syndrome","volume":"20","author":"Reith","year":"1996","journal-title":"Am J Surg Pathol"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1038\/jid.2013.405","article-title":"Propionibacterium acnes Induces IL-1\u03b2 secretion via the NLRP3 inflammasome in human monocytes","volume":"134","author":"Qin","year":"2014","journal-title":"J Invest Dermatol"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1111\/apm.12035","article-title":"Propionibacterium acnes activates caspase-1 in human neutrophils","volume":"121","author":"Sahdo","year":"2013","journal-title":"APMIS"},{"key":"B21","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1038\/nrrheum.2010.196","article-title":"Role of proinflammatory cytokines in the pathophysiology of osteoarthritis","volume":"7","author":"Kapoor","year":"2011","journal-title":"Nat Rev Rheumatol"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbspin.2017.04.010","article-title":"SAPHO, autophagy, IL-1, FoxO1, and Propionibacterium (Cutibacterium) acnes","volume":"85","author":"Berthelot","year":"2018","journal-title":"Joint Bone Spine"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1111\/j.1472-765x.2006.01866.x","article-title":"Propionibacterium acnes","volume":"42","author":"Perry","year":"2006","journal-title":"Lett Appl Microbiol"},{"key":"B24","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1159\/000324620","article-title":"Triggering role of focal infection in the induction of extra-palmoplantar lesions and pustulotic arthro-osteitis associated with palmoplantar pustulosis","volume":"72","author":"Yamamoto","year":"2011","journal-title":"Adv Otorhinolaryngol"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1080\/14397595.2018.1469580","article-title":"Serum levels of proinflammatory, anti-inflammatory cytokines, and RANKL\/OPG in synovitis, acne, pustulosis, hyperostosis, and osteitis (SAPHO) syndrome","volume":"29","author":"Zhang","year":"2019","journal-title":"Mod Rheumatol"},{"key":"B26","article-title":"Acne fulminans associated with arthritis in monozygotic twins","volume":"12","author":"Gonzalez","year":"1985","journal-title":"J Rheumatol"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/38.5.463","article-title":"SAPHO syndrome or psoriatic arthritis","volume":"38","author":"Dumolard","year":"1999","journal-title":"A familial Case study. Rheumatol (Oxford)"},{"key":"B28","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/s0901-5027(00)80125-3","article-title":"Diffuse chronic sclerosing osteomyelitis and the synovitis, acne, pustolosis, hyperostosis, osteitis (SAPHO) syndrome in two sisters","volume":"29","author":"Eyrich","year":"2000","journal-title":"Int J  Maxillofac Surg"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2005-09-3556","article-title":"Mutation of mouse Mayp\/Pstpip2 causes a macrophage autoinflammatory disease","volume":"107","author":"Grosse","year":"2006","journal-title":"Blood"},{"key":"B30","article-title":"Role of infectious agents in systemic rheumatic diseases","volume":"26","author":"Amital","year":"2008","journal-title":"Clin Exp Rheumatol"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1111\/1346-8138.12272","article-title":"Pustulotic arthro-osteitis associated with palmoplantar pustulosis","volume":"40","author":"Yamamoto","year":"2013","journal-title":"J Dermatol"},{"key":"B32","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1002\/path.2266","article-title":"Tonsillar crypt epithelium of palmoplantar pustulosis secretes interleukin-6 to support B-cell development via p63\/p73 transcription factors","volume":"214","author":"Koshiba","year":"2008","journal-title":"J Pathol"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1111\/1756-185x.14977","article-title":"Infection in SAPHO syndrome: Is it a reactive osteitis","volume":"27","author":"Huang","year":"2024","journal-title":"Int J Rheum Dis"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1007\/s10067-019-04904-8","article-title":"Demographic, clinical, and scintigraphic comparison of patients affected by palmoplantar pustulosis and severe acne: a retrospective study","volume":"39","author":"Li","year":"2020","journal-title":"Clin Rheumatol"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1111\/1756-185x.14064","article-title":"Tonsillitis as a possible predisposition to synovitis, acne, pustulosis, hyperostosis and osteitis (SAPHO) syndrome","volume":"24","author":"Xiang","year":"2021","journal-title":"Int J Rheum Dis"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.3109\/14397595.2013.874760","article-title":"Antibiotics may be useful in the treatment of SAPHO syndrome","volume":"24","author":"Colina","year":"2014","journal-title":"Mod Rheumatol"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.3109\/14397595.2013.874744","article-title":"Severe inflammation associated with synovitis, acne, pustulosis, hyperostosis, osteitis (SAPHO) syndrome was markedly ameliorated by single use of minocycline","volume":"24","author":"Takizawa","year":"2014","journal-title":"Mod Rheumatol"},{"key":"B38","doi-asserted-by":"publisher","first-page":"R140","DOI":"10.1186\/ar2812","article-title":"Efficacy of antibiotic therapy for SAPHO syndrome is lost after its discontinuation: an interventional study","volume":"11","author":"Assmann","year":"2009","journal-title":"Arthritis Res Ther"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1111\/1346-8138.14348","article-title":"Treatment outcome and prognostic factors of tonsillectomy for palmoplantar pustulosis and pustulotic arthro-osteitis: A retrospective subjective and objective quantitative analysis of 138 patients","volume":"45","author":"Takahara","year":"2018","journal-title":"J Dermatol"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1053\/ajkd.2001.27690","article-title":"Tonsillectomy and steroid pulse therapy significantly impact on clinical remission in patients with IgA nephropathy","volume":"38","author":"Hotta","year":"2001","journal-title":"Am J Kidney Dis"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/gfu020","article-title":"A multicenter randomized controlled trial of tonsillectomy combined with steroid pulse therapy in patients with immunoglobulin A nephropathy","volume":"29","author":"Kawamura","year":"2014","journal-title":"Nephrol Dial Transplant"},{"key":"B42","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1007\/s10157-015-1138-7","article-title":"Significance of tonsillectomy combined with steroid pulse therapy for IgA nephropathy with mild proteinuria","volume":"20","author":"Komatsu","year":"2016","journal-title":"Clin Exp Nephrol"},{"key":"B43","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1007\/s00431-018-3263-2","article-title":"The role of Cutibacterium acnes in auto-inflammatory bone disorders","volume":"178","author":"Zimmermann","year":"2019","journal-title":"Eur J Pediatr"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/ken185","article-title":"Characterization of the immune response in the synovitis, acne, pustulosis, hyperostosis, osteitis (SAPHO) syndrome","volume":"47","author":"Hurtado-Nedelec","year":"2008","journal-title":"Rheumatol (Oxford)"},{"key":"B45","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1177\/120347540500900605","article-title":"Off-label dermatologic uses of anti-TNF-a therapies","volume":"9","author":"Alexis","year":"2005","journal-title":"J Cutan Med Surg"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/keaa352","article-title":"Successful treatment of refractory mandibular lesions in SAPHO syndrome with secukinumab","volume":"60","author":"Sun","year":"2021","journal-title":"Rheumatol (Oxford)"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1007\/s11914-017-0405-9","article-title":"Chronic recurrent multifocal osteomyelitis (CRMO): presentation, pathogenesis, and treatment","volume":"15","author":"Hofmann","year":"2017","journal-title":"Curr Osteoporos Rep"},{"key":"B48","doi-asserted-by":"publisher","first-page":"1759720X20912865","DOI":"10.1177\/1759720x20912865","article-title":"Synovitis, acne, pustulosis, hyperostosis, and osteitis syndrome: review and update","volume":"12","author":"Liu","year":"2020","journal-title":"Ther Adv Musculoskelet Dis"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.1097\/md.0000000000016045","article-title":"Long-term remarkable remission of SAPHO syndrome in response to short-term systemic corticosteroids treatment in an immunoglobulin E elevated patient: A case report","volume":"98","author":"Wang","year":"2019","journal-title":"Med (Baltimore)"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.2174\/1874325000903010100","article-title":"SAPHO syndrome diagnosis and treatment: report of five cases and review of the literature","volume":"3","author":"Matzaroglou","year":"2009","journal-title":"Open Orthop J"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.1007\/s10067-017-3751-1","article-title":"Clinical heterogeneity of SAPHO syndrome: challenging diagnose and treatment","volume":"36","author":"Cianci","year":"2017","journal-title":"Clin Rheumatol"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.1016\/j.jadohealth.2014.02.004","article-title":"SAPHO syndrome in an adolescent: a clinical case with unusual severe systemic impact","volume":"55","author":"Freira","year":"2014","journal-title":"J Adolesc Health"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.24953\/turkjped.2017.02.011","article-title":"Successful treatment of a childhood synovitis, acne, pustulosis, hyperostosis and osteitis (SAPHO) syndrome with subcutaneous methotrexate: A case report","volume":"59","author":"Ak\u00e7aboy","year":"2017","journal-title":"Turk J Pediatr"},{"key":"B54","article-title":"Methotrexate to treat SAPHO syndrome with keloidal scars","volume":"36","author":"Azevedo","year":"2011","journal-title":"Acta Reumatol Port"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.3899\/jrheum.140342","article-title":"The SAPHO syndrome: a single-center study of 41 adult patients","volume":"42","author":"Aljuhani","year":"2015","journal-title":"J Rheumatol"},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.1016\/s0049-0172(99)80027-4","article-title":"SAPHO syndrome: a long-term follow-up study of 120 cases","volume":"29","author":"Hayem","year":"1999","journal-title":"Semin Arthritis Rheum"},{"key":"B57","article-title":"Reduction of peripheral natural killer cells in patients with SAPHO syndrome","volume":"37","author":"Xu","year":"2019","journal-title":"Clin Exp Rheumatol"},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.1097\/00007890-199502000-00013","article-title":"Differential effects of the immunosuppressive agents cyclosporine and leflunomide in vivo. Leflunomide blocks clonal T cell expansion yet allows production of lymphokines and manifestation of T cell-mediated shock","volume":"59","author":"Lang","year":"1995","journal-title":"Transplantation"},{"key":"B59","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1186\/s12967-017-1131-x","article-title":"The active metabolite of leflunomide, A77 1726, attenuates inflammatory arthritis in mice with spontaneous arthritis via induction of heme oxygenase-1","volume":"15","author":"Moon","year":"2017","journal-title":"J Transl Med"},{"key":"B60","doi-asserted-by":"publisher","DOI":"10.5114\/ceji.2014.43714","article-title":"Modulating effects of leflunomide on the balance of Th17\/Treg cells in collageninduced arthritis DBA\/1 mice","volume":"39","author":"Zhu","year":"2014","journal-title":"Cent Eur J Immunol"},{"key":"B61","doi-asserted-by":"publisher","DOI":"10.1684\/ejd.2016.2854","article-title":"Interstitial granulomatous dermatitis occurring in a patient with SAPHO syndrome one month after starting leflunomide, and subsequently disappearing with ustekinumab","volume":"26","author":"Cornillier","year":"2016","journal-title":"Eur J Dermatol"},{"key":"B62","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1186\/s12969-019-0353-2","article-title":"Chronic non-bacterial osteomyelitis: a comparative study between children and adults","volume":"17","author":"Skrabl-Baumgartner","year":"2019","journal-title":"Pediatr Rheumatol Online J"},{"key":"B63","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1186\/1546-0096-12-30","article-title":"Deregulation of the IL-1\u03b2 axis in chronic recurrent multifocal osteomyelitis","volume":"12","author":"Scianaro","year":"2014","journal-title":"Pediatr Rheumatol Online J"},{"key":"B64","doi-asserted-by":"publisher","DOI":"10.1016\/j.clim.2015.09.013","article-title":"Altered expression of IL-10 family cytokines in monocytes from CRMO patients result in enhanced IL-1\u03b2 expression and release","volume":"161","author":"Hofmann","year":"2015","journal-title":"Clin Immunol"},{"key":"B65","doi-asserted-by":"publisher","DOI":"10.3109\/08916934.2014.906582","article-title":"TH17 cells are increased in the peripheral blood of patients with SAPHO syndrome","volume":"47","author":"Firinu","year":"2014","journal-title":"Autoimmunity"},{"key":"B66","doi-asserted-by":"publisher","DOI":"10.1136\/ard.61.4.375","article-title":"Successful treatment of SAPHO syndrome with infliximab: report of two cases","volume":"61","author":"Olivieri","year":"2002","journal-title":"Ann Rheum Dis"},{"key":"B67","doi-asserted-by":"publisher","DOI":"10.1002\/art.10539","article-title":"Sustained response to tumor necrosis factor alpha-blocking agents in two patients with SAPHO syndrome","volume":"46","author":"Wagner","year":"2002","journal-title":"Arthritis Rheum"},{"key":"B68","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2004.09.006","article-title":"Acne fulminans with synovitis-acne-pustulosis-hyperostosis-osteitis (SAPHO) syndrome treated with infliximab","volume":"52","author":"Iqbal","year":"2005","journal-title":"J Am Acad Dermatol"},{"key":"B69","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/kei221","article-title":"In SAPHO syndrome anti-TNF-alpha therapy may induce persistent amelioration of osteoarticular complaints, but may exacerbate cutaneous manifestations","volume":"45","author":"Massara","year":"2006","journal-title":"Rheumatol (Oxford)"},{"key":"B70","doi-asserted-by":"publisher","DOI":"10.1007\/s10067-007-0767-y","article-title":"Infliximab can induce a prolonged clinical remission and a decrease in thyroid hormonal requirements in a patient with SAPHO syndrome and hypothyroidism","volume":"27","author":"Sabugo","year":"2008","journal-title":"Clin Rheumatol"},{"key":"B71","doi-asserted-by":"publisher","DOI":"10.2165\/11593250-000000000-00000","article-title":"Long-term treatment of severe SAPHO syndrome with adalimumab: case report and a review of the literature","volume":"13","author":"Garcovich","year":"2012","journal-title":"Am J Clin Dermatol"},{"key":"B72","doi-asserted-by":"publisher","DOI":"10.1007\/s10067-010-1476-5","article-title":"Successful treatment of SAPHO syndrome with adalimumab: a case report","volume":"29","author":"Castellv\u00ed","year":"2010","journal-title":"Clin Rheumatol"},{"key":"B73","doi-asserted-by":"publisher","DOI":"10.1111\/ijd.12675","article-title":"Etanercept in the treatment of SAPHO syndrome","volume":"54","author":"S\u00e1ez-Mart\u00edn","year":"2015","journal-title":"Int J Dermatol"},{"key":"B74","doi-asserted-by":"publisher","DOI":"10.1007\/s00296-011-1916-9","article-title":"Successful treatment of SAPHO syndrome with severe spinal disorder using entercept: a case study","volume":"32","author":"Zhang","year":"2012","journal-title":"Rheumatol Int"},{"key":"B75","doi-asserted-by":"publisher","first-page":"adv00698","DOI":"10.2340\/actadv.v102.563","article-title":"Long-term safety of secukinumab over five years in patients with moderate-to-severe plaque psoriasis, psoriatic arthritis and ankylosing spondylitis: update on integrated pooled clinical trial and post-marketing surveillance data","volume":"102","author":"Gottlieb","year":"2022","journal-title":"Acta Derm Venereol"},{"key":"B76","doi-asserted-by":"publisher","DOI":"10.1007\/s13555-019-00340-3","article-title":"Safety of ixekizumab treatment for up to 5 years in adult patients with moderate-to-severe psoriasis: results from greater than 17,000 patient-years of exposure","volume":"10","author":"Armstrong","year":"2020","journal-title":"Dermatol Ther (Heidelb)"},{"key":"B77","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1007\/s10067-018-4083-5","article-title":"Paradoxical skin lesions induced by anti-TNF-\u03b1 agents in SAPHO syndrome","volume":"38","author":"Li","year":"2019","journal-title":"Clin Rheumatol"},{"key":"B78","doi-asserted-by":"publisher","first-page":"100211","DOI":"10.1016\/j.jtauto.2023.100211","article-title":"Paradoxical psoriasis: The flip side of idiopathic psoriasis or an autocephalous reversible drug reaction","volume":"7","author":"Lu","year":"2023","journal-title":"J Transl Autoimmun"},{"key":"B79","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/j.cyto.2016.08.014","article-title":"Molecular mechanisms of action of anti-TNF-\u03b1 agents - Comparison among therapeutic TNF-\u03b1 antagonists","volume":"101","author":"Mitoma","year":"2018","journal-title":"Cytokine"},{"key":"B80","doi-asserted-by":"publisher","first-page":"bcr2012007161","DOI":"10.1136\/bcr-2012-007161","article-title":"Successful treatment of resistant SAPHO syndrome with anti-TNF therapy","volume":"2013","author":"Hampton","year":"2013","journal-title":"BMJ Case Rep"},{"key":"B81","doi-asserted-by":"publisher","DOI":"10.1016\/j.semarthrit.2018.09.004","article-title":"Spinal and sacroiliac involvement in SAPHO syndrome: A single center study of a cohort of 354 patients","volume":"48","author":"Cao","year":"2019","journal-title":"Semin Arthritis Rheum"},{"key":"B82","doi-asserted-by":"publisher","DOI":"10.2169\/internalmedicine.8473-16","article-title":"Adult-onset chronic recurrent multifocal osteomyelitis with high intensity of muscles detected by magnetic resonance imaging, successfully controlled with tocilizumab","volume":"56","author":"Sato","year":"2017","journal-title":"Intern Med"},{"key":"B83","doi-asserted-by":"publisher","DOI":"10.1111\/1756-185x.12525","article-title":"Development of aseptic subcutaneous abscess after tocilizumab therapy in a patient with SAPHO syndrome complicated by amyloid A amyloidosis","volume":"18","author":"Fujita","year":"2015","journal-title":"Int J Rheum Dis"},{"key":"B84","doi-asserted-by":"publisher","DOI":"10.1177\/0300060518806105","article-title":"Failure of tocilizumab in treating two patients with refractory SAPHO syndrome: a case report","volume":"46","author":"Sun","year":"2018","journal-title":"J Int Med Res"},{"key":"B85","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.2010.09819.x","article-title":"Novel findings of Langerhans cells and interleukin-17 expression in relation to the acrosyringium and pustule in palmoplantar pustulosis","volume":"163","author":"Hagforsen","year":"2010","journal-title":"Br J Dermatol"},{"key":"B86","doi-asserted-by":"publisher","DOI":"10.1016\/j.jdermsci.2016.09.019","article-title":"Palmoplantar pustular psoriasis (PPPP) is characterized by activation of the IL-17A pathway","volume":"85","author":"Bissonnette","year":"2017","journal-title":"J Dermatol Sci"},{"key":"B87","doi-asserted-by":"publisher","DOI":"10.1111\/jdv.12272","article-title":"Increased expression of IL-17A and limited involvement of IL-23 in patients with palmo-plantar (PP) pustular psoriasis or PP pustulosis; results from a randomised controlled trial","volume":"28","author":"Bissonnette","year":"2014","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"B88","doi-asserted-by":"publisher","DOI":"10.1097\/md.0000000000030065","article-title":"Exceptional response of skin symptoms to secukinumab treatment in a patient with SAPHO syndrome: Case report and literature review","volume":"101","author":"Ji","year":"2022","journal-title":"Med (Baltimore)"},{"key":"B89","doi-asserted-by":"publisher","DOI":"10.3899\/jrheum.201260","article-title":"Clinical and radiological remission of osteoarticular and cutaneous lesions in SAPHO patients treated with secukinumab: A case series","volume":"48","author":"Wang","year":"2021","journal-title":"J Rheumatol"},{"key":"B90","doi-asserted-by":"publisher","first-page":"6005531","DOI":"10.1155\/2023\/6005531","article-title":"SAPHO syndrome complicated by lesions of the central nervous system successfully treated with brodalumab","volume":"2023","author":"Funabiki","year":"2023","journal-title":"Case Rep Rheumatol"},{"key":"B91","doi-asserted-by":"publisher","DOI":"10.1001\/jamaneurol.2020.1162","article-title":"Association between tumor necrosis factor inhibitor exposure and inflammatory central nervous system events","volume":"77","author":"Kunchok","year":"2020","journal-title":"JAMA Neurol"},{"key":"B92","doi-asserted-by":"publisher","DOI":"10.1007\/s12328-023-01893-9","article-title":"Colitis induced by IL-17A-inhibitors","volume":"17","author":"Gr\u00fcmme","year":"2024","journal-title":"Clin J Gastroenterol"},{"key":"B93","doi-asserted-by":"publisher","DOI":"10.1001\/jamadermatol.2013.256","article-title":"Ustekinumab therapy for severe interstitial granulomatous dermatitis with arthritis","volume":"149","author":"Leloup","year":"2013","journal-title":"JAMA Dermatol"},{"key":"B94","doi-asserted-by":"publisher","DOI":"10.1016\/j.jdcr.2021.05.029","article-title":"Rapid and sustained remission of synovitis, acne, pustulosis, hyperostosis, and osteitis (SAPHO) syndrome with IL-23p19 antagonist (risankizumab)","volume":"14","author":"Flora","year":"2021","journal-title":"JAAD Case Rep"},{"key":"B95","doi-asserted-by":"publisher","DOI":"10.1111\/dth.14758","article-title":"SAPHO syndrome successful treated with tildrakizumab","volume":"34","author":"Licata","year":"2021","journal-title":"Dermatol Ther"},{"key":"B96","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2011-200743","article-title":"Anakinra treatment of SAPHO syndrome: short-term results of an open study","volume":"71","author":"Wendling","year":"2012","journal-title":"Ann Rheum Dis"},{"key":"B97","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/keq122","article-title":"Biologic therapy in refractory chronic non-bacterial osteomyelitis of childhood","volume":"49","author":"Eleftheriou","year":"2010","journal-title":"Rheumatol (Oxford)"},{"key":"B98","doi-asserted-by":"publisher","first-page":"106480","DOI":"10.1016\/j.intimp.2020.106480","article-title":"The off-label uses profile of tofacitinib in systemic rheumatic diseases","volume":"83","author":"Zhao","year":"2020","journal-title":"Int Immunopharmacol"},{"key":"B99","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2020-217854","article-title":"Off-label use of tofacitinib: a potential treatment option for SAPHO syndrome","volume":"81","author":"Xie","year":"2022","journal-title":"Ann Rheum Dis"},{"key":"B100","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2011.150284","article-title":"The JAK inhibitor CP-690,550 (tofacitinib) inhibits TNF-induced chemokine expression in fibroblast-like synoviocytes: autocrine role of type I interferon","volume":"71","author":"Rosengren","year":"2012","journal-title":"Ann Rheum Dis"},{"key":"B101","doi-asserted-by":"publisher","DOI":"10.1002\/art.34329","article-title":"The JAK inhibitor tofacitinib regulates synovitis through inhibition of interferon-\u03b3 and interleukin-17 production by human CD4+ T cells","volume":"64","author":"Maeshima","year":"2012","journal-title":"Arthritis Rheum"},{"key":"B102","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.911922","article-title":"SAPHO syndrome complicated by ankylosing spondylitis successfully treated with tofacitinib: A case report","volume":"13","author":"Yuan","year":"2022","journal-title":"Front Immunol"},{"key":"B103","doi-asserted-by":"publisher","DOI":"10.1111\/ijd.17075","article-title":"Tofacitinib: a successful treatment option for SAPHO syndrome","volume":"63","author":"Sarikaya","year":"2024","journal-title":"Int J Dermatol"},{"key":"B104","doi-asserted-by":"publisher","DOI":"10.1111\/1756-185x.14628","article-title":"SAPHO syndrome with Takayasu arteritis successfully treated with tofacitinib","volume":"26","author":"Ru","year":"2023","journal-title":"Int J Rheum Dis"},{"key":"B105","doi-asserted-by":"publisher","DOI":"10.1111\/1756-185X.14693","article-title":"SAPHO syndrome complicated with relapsing polychondritis: A case report","volume":"26","author":"Cao","year":"2023","journal-title":"Int J Rheum Dis"},{"key":"B106","doi-asserted-by":"publisher","DOI":"10.1001\/jamadermatol.2020.3095","article-title":"Tofacitinib for the treatment of nail lesions and palmoplantar pustulosis in synovitis, acne, pustulosis, hyperostosis, and osteitis syndrome","volume":"157","author":"Li","year":"2021","journal-title":"JAMA Dermatol"},{"key":"B107","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000011149","article-title":"Case report: successful treatment of refractory SAPHO syndrome with the JAK inhibitor tofacitinib","volume":"97","author":"Yang","year":"2018","journal-title":"Med (Baltimore)"},{"key":"B108","doi-asserted-by":"publisher","DOI":"10.1111\/1756-185x.14542","article-title":"Synovitis, acne, pustulosis, hyperostosis and osteitis syndrome with mandibular involvement: Would surgical operation help","volume":"26","author":"Liu","year":"2023","journal-title":"Int J Rheum Dis"},{"key":"B109","doi-asserted-by":"publisher","DOI":"10.2147\/CCID.S392909","article-title":"Synovitis, acne, pustulosis, hyperostosis and osteitis (SAPHO) syndrome with henoch-sch\u00f6nlein purpura: A case report","volume":"16","author":"Wang","year":"2023","journal-title":"Clin Cosmet Invest Dermatol"},{"key":"B110","doi-asserted-by":"publisher","first-page":"6201887","DOI":"10.1155\/2023\/6201887","article-title":"A case of SAPHO syndrome complicated by uveitis with good response to both TNF inhibitor and JAKinib","volume":"2023","author":"Baisya","year":"2023","journal-title":"Case Rep Rheumatol"},{"key":"B111","doi-asserted-by":"publisher","DOI":"10.1016\/j.jdcr.2019.03.024","article-title":"Palmoplantar pustulosis-like eruption following tofacitinib therapy for juvenile idiopathic arthritis","volume":"5","author":"Shibata","year":"2019","journal-title":"JAAD Case Rep"},{"key":"B112","doi-asserted-by":"publisher","first-page":"105587","DOI":"10.1016\/j.jbspin.2023.105587","article-title":"Efficacy of baricitinib in synovitis, acne, pustulosis, hyperostosis, and osteitis syndrome: A case series","volume":"90","author":"Liu","year":"2023","journal-title":"Joint Bone Spine"},{"key":"B113","doi-asserted-by":"publisher","DOI":"10.2147\/CCID.S446468","article-title":"Successful treatment of refractory synovitis, acne, pustulosis, hyperostosis, and osteitis (SAPHO) syndrome with baricitinib, a janus kinase inhibitor","volume":"17","author":"Yang","year":"2024","journal-title":"Clin Cosmet Invest Dermatol"},{"key":"B114","doi-asserted-by":"publisher","first-page":"rkac084","DOI":"10.1093\/rap\/rkac084","article-title":"Successful treatment of hip involvement in SAPHO syndrome with baricitinib","volume":"6","author":"Wuriliga","year":"2022","journal-title":"Rheumatol Adv Pract"},{"key":"B115","doi-asserted-by":"publisher","DOI":"10.1111\/1756-185x.14774","article-title":"Novel JAK-1 inhibitor upadacitinib as a possible treatment for refractory SAPHO syndrome: A case report","volume":"26","author":"Ma","year":"2023","journal-title":"Int J Rheum Dis"},{"key":"B116","doi-asserted-by":"publisher","DOI":"10.2147\/JIR.S353539","article-title":"New insights in the treatment of SAPHO syndrome and medication recommendations","volume":"15","author":"Cheng","year":"2022","journal-title":"J Inflammation Res"},{"key":"B117","doi-asserted-by":"publisher","DOI":"10.1111\/dth.14261","article-title":"Apremilast in dermatology: A review of literature","volume":"33","author":"Nassim","year":"2020","journal-title":"Dermatol Ther"},{"key":"B118","doi-asserted-by":"publisher","DOI":"10.1111\/bjd.16071","article-title":"Successful treatment of SAPHO syndrome with apremilast","volume":"179","author":"Adamo","year":"2018","journal-title":"Br J Dermatol"},{"key":"B119","doi-asserted-by":"publisher","first-page":"2300743","DOI":"10.1080\/09546634.2023.2300743","article-title":"Is apremilast a treatment for SAPHO syndrome","volume":"35","author":"Zhang","year":"2024","journal-title":"J Dermatolog Treat"},{"key":"B120","doi-asserted-by":"publisher","DOI":"10.1034\/j.1399-3038.13.s.15.7.x","article-title":"Clinical course of cow\u2019s milk protein allergy\/intolerance and atopic diseases in childhood","volume":"13","author":"H\u00f8st","year":"2002","journal-title":"Pediatr Allergy Immunol"},{"key":"B121","doi-asserted-by":"publisher","DOI":"10.1056\/nejmra1100030","article-title":"Genomics and the multifactorial nature of human autoimmune disease","volume":"365","author":"Cho","year":"2011","journal-title":"N Engl J Med"},{"key":"B122","doi-asserted-by":"publisher","first-page":"1034","DOI":"10.3390\/medicina58081034","article-title":"Genetic polymorphism of PTPN22 in autoimmune diseases: A comprehensive review","volume":"58","author":"Tizaoui","year":"2022","journal-title":"Medicina (Kaunas)"},{"key":"B123","doi-asserted-by":"publisher","DOI":"10.1023\/a:1016281608773","article-title":"Effect of liposomal and free bisphosphonates on the IL-1 beta, IL-6 and TNF alpha secretion from RAW 264 cells in vitro","volume":"12","author":"Pennanen","year":"1995","journal-title":"Pharm Res"},{"key":"B124","article-title":"In vitro effect of (3-amino-1-hydroxypropylidene)-1,1-bisphosphonic acid (APD) on the function of mononuclear phagocytes in lymphocyte proliferation","volume":"47","author":"de Vries","year":"1982","journal-title":"Immunology"},{"key":"B125","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/keh295","article-title":"Pamidronate in the treatment of childhood SAPHO syndrome","volume":"43","author":"Kerrison","year":"2004","journal-title":"Rheumatol (Oxford)"},{"key":"B126","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1093\/rheumatology\/keh466","article-title":"SAPHO syndrome and pamidronate revisited","volume":"44","author":"Valls-Roc","year":"2005","journal-title":"Rheumatol (Oxford)"},{"key":"B127","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/kei160","article-title":"The usefulness of bone remodelling markers in predicting the efficacy of pamidronate treatment in SAPHO syndrome","volume":"45","author":"Solau-Gervais","year":"2006","journal-title":"Rheumatol (Oxford)"},{"key":"B128","article-title":"Sustained remission of SAPHO syndrome with pamidronate: a follow-up of fourteen cases and a review of the literature","volume":"27","author":"Colina","year":"2009","journal-title":"Clin Exp Rheumatol"},{"key":"B129","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbspin.2014.01.017","article-title":"SAPHO syndrome treatment with intravenous pamidronate. Retrospective study of 22 patients","volume":"81","author":"Delattre","year":"2014","journal-title":"Joint Bone Spine"},{"key":"B130","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/41.10.1196","article-title":"Treatment of SAPHO with pamidronate","volume":"41","author":"Courtney","year":"2002","journal-title":"Rheumatol (Oxford)"},{"key":"B131","article-title":"Efficacy of bisphosphonates in patients with synovitis, acne, pustulosis, hyperostosis, and osteitis syndrome: a prospective open study","volume":"37","author":"Li","year":"2019","journal-title":"Clin Exp Rheumatol"},{"key":"B132","doi-asserted-by":"publisher","DOI":"10.1016\/s1297-319x(02)00419-0","article-title":"Pamidronate treatment in SAPHO syndrome","volume":"69","author":"Guignard","year":"2002","journal-title":"Joint Bone Spine"},{"key":"B133","article-title":"A single cohort, open-label study of the efficacy of pamidronate for palmoplantar pustulosis in synovitis, acne, pustulosis, hyperostosis and osteitis (SAPHO) syndrome","volume":"38","author":"Wu","year":"2020","journal-title":"Clin Exp Rheumatol"},{"key":"B134","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/41.2.231-a","article-title":"Pamidronate: a novel treatment for the SAPHO syndrome","volume":"41","author":"Marshall","year":"2002","journal-title":"Rheumatol (Oxford)"},{"key":"B135","doi-asserted-by":"publisher","DOI":"10.55563\/clinexprheumatol\/zpgyz9","article-title":"Short-term efficacy of zoledronic acid in the treatment of 30 cases of SAPHO syndrome","volume":"42","author":"Liu","year":"2024","journal-title":"Clin Exp Rheumatol"},{"key":"B136","doi-asserted-by":"publisher","DOI":"10.1007\/s00296-008-0760-z","article-title":"Successful treatment of SAPHO syndrome with an oral bisphosphonate","volume":"29","author":"Ichikawa","year":"2009","journal-title":"Rheumatol Int"},{"key":"B137","doi-asserted-by":"publisher","DOI":"10.1002\/art.20464","article-title":"Successful treatment of SAPHO syndrome with zoledronic acid","volume":"50","author":"Kopterides","year":"2004","journal-title":"Arthritis Rheum"},{"key":"B138","doi-asserted-by":"publisher","DOI":"10.1111\/j.1610-0387.2008.06588.x","article-title":"Successful treatment of primary chronic osteomyelitis in SAPHO syndrome with bisphosphonates","volume":"6","author":"Just","year":"2008","journal-title":"J Dtsch Dermatol Ges"},{"key":"B139","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1097\/rhu.0b013e3181e9be89","article-title":"Successful treatment of SAPHO syndrome with ibandronate","volume":"16","author":"Soyfoo","year":"2010","journal-title":"J Clin Rheumatol"},{"key":"B140","doi-asserted-by":"publisher","first-page":"13030\/qt28x3f2g6","DOI":"10.5070\/d3265048786","article-title":"SAPHO syndrome: the value of classic drugs in the era of biologics","volume":"26","author":"Gil","year":"2020","journal-title":"Dermatol Online J"},{"key":"B141","doi-asserted-by":"publisher","first-page":"e21691","DOI":"10.1016\/j.heliyon.2023.e21691","article-title":"Effectiveness and safety of 99Tc-methylene diphosphonate as a disease-modifying anti-rheumatic drug (DMARD) in combination with conventional synthetic (cs) DMARDs in the treatment of rheumatoid arthritis: A systematic review and meta-analysis of 34 randomized controlled trials","volume":"9","author":"Deng","year":"2023","journal-title":"Heliyon"},{"key":"B142","doi-asserted-by":"publisher","DOI":"10.1097\/scs.0000000000006161","article-title":"SAPHO syndrome involving the mandible treated with 99Tc-MDP","volume":"31","author":"Shao","year":"2020","journal-title":"J Craniofac Surg"},{"key":"B143","doi-asserted-by":"publisher","DOI":"10.1002\/jbmr.3017","article-title":"Uncertainty of current algorithm for bisphosphonate-related osteonecrosis of the jaw in population-based studies: a systematic review","volume":"32","author":"Kim","year":"2017","journal-title":"J Bone Miner Res"},{"key":"B144","doi-asserted-by":"publisher","first-page":"101103","DOI":"10.1016\/j.disamonth.2020.101103","article-title":"Acne in the first three decades of life: An update of a disorder with profound implications for all decades of life","volume":"67","author":"Greydanus","year":"2021","journal-title":"Dis Mon"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2025.1560398\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,15]],"date-time":"2025-04-15T01:21:12Z","timestamp":1744680072000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2025.1560398\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,15]]},"references-count":144,"alternative-id":["10.3389\/fimmu.2025.1560398"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2025.1560398","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,15]]},"article-number":"1560398"}}